Unsere Gruppe organisiert über 3000 globale Konferenzreihen Jährliche Veranstaltungen in den USA, Europa und anderen Ländern. Asien mit Unterstützung von 1000 weiteren wissenschaftlichen Gesellschaften und veröffentlicht über 700 Open Access Zeitschriften, die über 50.000 bedeutende Persönlichkeiten und renommierte Wissenschaftler als Redaktionsmitglieder enthalten.
Open-Access-Zeitschriften gewinnen mehr Leser und Zitierungen
700 Zeitschriften und 15.000.000 Leser Jede Zeitschrift erhält mehr als 25.000 Leser
Tan Navdeep gri
A loss of kidney function causes metabolic acidosis in patients with chronic kidney disease (CKD). It has been linked to CKD progression, mortality from all causes, and other negative outcomes. Our goal was to see if metabolic acidosis is linked to an increased risk of acute kidney injury (AKI).
Chronic kidney disease (CKD) is a prevalent and serious health condition characterized by the progressive deterioration of renal function. It affects individuals of all age groups and is associated with significant morbidity and mortality rates. CKD develops as a result of various underlying etiologies, including diabetes, hypertension, glomerulonephritis,and genetic disorders. The pathophysiology involves a complex interplay of inflammation, oxidative stress, fibrosis,and impaired renal function. CKD is associated with a wide range of complications, such as cardiovascular disease,mineral and bone disorders, anemia, and electrolyte imbalances. Early detection and management of CKD are crucialto slow theprogression of the disease, delay the onset of complications, and improve outcomes. The management of CKD involves a multidisciplinary approach, including lifestyle modifications, pharmacological interventions, and renal replacement therapy in advanced stages. Renal transplantation is considered the gold standard treatment for ESRD, offering the best long-term outcomes and improved quality of life. However, access to transplantation is limited, and many patients rely on dialysis for survival. CKD imposes a substantial burden on healthcare systems, emphasizing the importance of preventive strategies, early detection, and comprehensive management to reduce the global impact of CKD. Future research efforts should focus on identifying novel therapeutic targets, improving diagnostic techniques, and implementing effective strategies for CKD prevention and management.
The abstract provided here is a general representation and does not include specific details or statistics. The content can vary depending on the scope and focus of the research or article being summarized.